TYRX Release: Nearly 50% of Patients With Cardiac Device Infections Don’t Survive Beyond Three Years
5/10/2013 12:42:40 PM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
DENVER--(BUSINESS WIRE)--The incremental mortality in implantable pacemaker and defibrillator recipients who experience a device infection, compared to patients without device infection, is substantial and persists for at least three years after index hospitalization with infection. These are the key findings of a retrospective cohort study of 200,219 Medicare fee-for-service patients undergoing cardiac device procedures, with and without infection, that were presented today by M. Rizwan Sohail, MD, a researcher from the Mayo Clinic Divisions of Infectious Diseases and Cardiovascular Diseases, at Heart Rhythm 2013, the Heart Rhythm Society’s 34th Annual Scientific Sessions.
Help employers find you! Check out all the jobs and post your resume.
comments powered by